NDC 69842-290-08 - MAXIMUM STRENGTH DAYTIME NIGHTTIME SINUS RELIEF
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 69842-290
- Requested NDC
- 69842-290-08
- Package NDCs from labels
- 69842-290-08
- Manufacturer
- CVS Pharmacy, Inc. | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED
- Effective date
- 2026-03-26
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| 630T CVS 69842-442 MAXIMUM STRENGTH DAYTIME NIGHTTIME SINUS RELIEF | CVS Pharmacy, Inc. | TIME CAP LABORATORIES, INC. | MARKSANS PHARMA LIMITED | 2026-03-26 | HUMAN OTC DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 69842-290-08 | MAXIMUM STRENGTH DAYTIME NIGHTTIME SINUS RELIEF | 8 in 1 BLISTER PACK | CAPSULE, LIQUID FILLED | 8 | 6.25 mg | 4 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 69842-290 | MAXIMUM STRENGTH DAYTIME NIGHTTIME SINUS RELIEF (ACETAMINOPHEN DEXTROMETHORPHAN HBR GUAIFENESIN PHENYLEPHRINE HCL AND ACETAMINOPHEN DEXTROMETHORPHAN HBR DOXYLAMINE SUCCINATE PHENYLEPHRINE HCL) KIT [CVS PHARMACY, INC.] | 3 | Unmatched | 20250215_c17d5ba7-3302-7931-e053-2a95a90a5a6c.zip |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| HERA SILKYSTAY FOUNDATION 44C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f42d960-6b86-b4cd-e063-6294a90a98f3 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 45N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4326fc-b3c3-1a8b-e063-6294a90a8d9b | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 45W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4335c8-596f-3269-e063-6294a90a6c3d | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 46W1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f43404e-bdab-3f4b-e063-6294a90ab881 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 47N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f435148-dcb1-cfdf-e063-6394a90aa8b6 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 50N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f43610f-6c4f-dd9d-e063-6394a90ab60a | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 48N1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4372c4-b87a-91ab-e063-6294a90a6807 | 2026-11-01 | Warnings | 15FIX9V2JP |
| HERA SILKYSTAY FOUNDATION 49C1 | TITANIUM DIOXIDE | Amorepacific Corporation | 5f4380d1-2cf4-1fd8-e063-6394a90a0aa3 | 2026-11-01 | Warnings | 15FIX9V2JP |
| FGPER NASAL DECONGESTANT | OXYMETAZOLINE HYDROCHLORIDE | Guangzhou ChuanMa International Trading Co.,Ltd. | 5f1d9ad2-fc66-0107-e063-6294a90a952d | 2026-10-31 | Warnings | M012 |
| Guaifenesin 600 mg | GUAIFENESIN | Redpharm Drug | 5f1e9c28-f787-ea6d-e063-6394a90a5edd | 2026-10-31 | Warnings | 495W7451VQ |
| Childrens Mucus and Cough Relief | GUAIFENESIN AND DEXTROMETHORPHAN HYDROBROMIDE | Chain Drug Manufacturing Assn | 06822a28-3f82-471d-8db5-c5981b263a03 | 2026-10-30 | Warnings | M012 9D2RTI9KYH 495W7451VQ |
| Quality Choice Severe Cold and Cough Nighttime | ACETAMINOPHEN, DIPHENHYDRAMINE, PHENYLEPHRINE | Chain Drug Manufacturing Assn | ce658dd5-b683-436e-b16b-0c06f6f87fd9 | 2026-10-30 | Warnings | M012 04JA59TNSJ 362O9ITL9D |
| ACETAMINOPHEN | ACETAMINOPHEN | Amazon.com Services LLC | 9cdfa6fb-4bc5-4a54-93fc-edd84bf80ef3 | 2026-10-30 | Warnings | 362O9ITL9D |
| Hemorrhoid Anesthetic | MINERAL OIL, PETROLATUM, PHENYLEPHRINE HCL | Savvy Care and Cosmetics | 5f0afbf4-3a61-1aab-e063-6394a90a3fe6 | 2026-10-30 | Warnings | 04JA59TNSJ |
| Headache Relief | ACETAMINOPHEN, ASPIRIN, CAFFEINE | LEADER/ Cardinal Health 110, Inc. | b3773f02-02a9-33c8-e053-2995a90a2235 | 2026-10-30 | Warnings | 362O9ITL9D |
| Multi-Symptom Allergy | ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, PHENYLEPHRINE HCL | Walgreen Company | 5170c450-989d-44fa-ab38-86c78feae3b6 | 2026-10-30 | Warnings | M012 04JA59TNSJ 362O9ITL9D |
| Childrens Mucus Relief Chest Congestion | GUAIFENESIN | Chain Drug Manufacturing Assn | 034d39c0-9aad-4dff-a158-a041b9f0504f | 2026-10-30 | Warnings | M012 495W7451VQ |
| tussin severe | ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, GUAIFENESIN, PHENYLEPHRINE HYDROCHLORIDE | H E B | 7cc2c136-d1b7-4658-99bb-73bb1d140261 | 2026-10-30 | Warnings | M012 9D2RTI9KYH 04JA59TNSJ 362O9ITL9D 495W7451VQ |
| Quality Choice | OXYMETAZOLINE HYDROCHLORIDE | CHAIN DRUG MARKETING ASSOCIATION | d01b8fb6-1ddf-4901-bda6-ae608e94a6a4 | 2026-10-30 | Warnings | M012 |
| Acetaminophen | ACETAMINOPHEN | PAI Holdings, LLC dba PAI Pharma | 6ec12573-03d6-40c1-9945-d345b401e062 | 2026-10-30 | Warnings | 362O9ITL9D |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.